Station 41

Bridging Innovation and Impact with Southern Research

Station 41 stands as a testament to Southern Research’s enduring commitment to scientific advancement and community enrichment. Established in 2024 on Southern Research’s Birmingham campus, this biotech commercialization hub accelerates the journey from groundbreaking research to real-world applications. By providing state-of-the-art laboratory spaces, mentorship, and critical resources, Station 41 empowers startups to transform innovative ideas into impactful solutions.

Empowering Biotech Startups:

Incubator: Private wet labs and offices equipped with shared lab equipment and services to support biotech startup growth.
Accelerator: Non-dilutive funding up to $300,000 to advance therapeutics discovery projects, in collaboration with UAB.
Therapeutics Development Fund: In-kind technical and entrepreneurial support for companies in Alabama, supported by Innovate Alabama.
New Ventures: Opportunities for licensing and commercialization partnerships to advance biotech products.

Learn More

FAQs:

What is Station 41?

Station 41 is a biotechnology commercialization hub powered by Southern Research, providing resources and support to biotech startups.

How can startups apply to join Station 41?

Startups can express their interest by filling out the application form on the Station 41 website.

What types of companies does Station 41 support?

Station 41 supports companies involved in treating and diagnosing diseases, especially those aligned with Southern Research’s core focus areas: cancer, infectious diseases, and chronic diseases.